Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2005
04/05/2005US6875753 Transplanting stem cells; stimulate releasing of hematopoietic cells
04/05/2005US6875752 Therapy for grampositive bacteria; bactericides
04/05/2005US6875750 Methylation of target compound using methyltransferase
04/05/2005US6875746 Anticancer anthraquinones and method of use thereof
04/05/2005US6875745 Synergistic mixture of lapachone and taxane; anticancer, antitumor agents
04/05/2005US6875740 Combination of a cyclic hexapeptide with antifungal drugs for treatment of fungal pathogens
04/05/2005US6875736 Methods for identifying RNA binding compounds
04/05/2005US6875599 Enzymatic protein for use in the treatment of inflammation, cancers, cardiovascular, brain, respiratory and crohn's disease
04/05/2005US6875576 Detection of modulators of receptor binding activity; obtain sample containing receptor, incubate with modulator, monitor adjustment of binding activity of receptor
04/05/2005US6875570 Proteins and nucleic acids encoding same
04/05/2005US6875453 Non-toxic disinfectant containing a isopropyl alcohol and sesame oil composition with lemon oil and menthol
04/05/2005US6875452 Mixture of plant oil with benzoic acid or paraben compound ; microbiocide
04/05/2005US6875451 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
04/05/2005US6875449 Crystal structure
04/05/2005US6875447 Analgesics; pain therapy; administering by injection
04/05/2005US6875446 Method for prophylaxis and/or treatment of thromboembolism
04/05/2005US6875445 Includes a quantity of calcium acetate sufficient to bind phosphorous in gastrointestinal tract of the individual
04/05/2005US6875443 An alcohol with chain length from about c20-c36 including policosanol, are therapeutically useful materials with efficacy in lowering cholesterol, can be advantageously added to foods such as margarines and salad dressings
04/05/2005US6875439 Controlling drug resistance; intensify therapy; increas accumulation in cell
04/05/2005US6875429 Transferring cancer cells to noncancer tumor; injecting into animal
04/05/2005US6875428 Especially endcapped polyethylene glycols, polypropylene glycols or copolymers of them
04/05/2005US6875423 Methods for increasing peripheral blood circulation
04/05/2005US6875422 Oral treatment/care agent
04/05/2005US6874565 Cooling apparatus
04/05/2005US6874446 Animal brushes
04/05/2005CA2371012C 4-(1h-pyrrol-1-yl) imidazoles
04/05/2005CA2339621C 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists
04/05/2005CA2276146C Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants
04/05/2005CA2270086C New benzothiophene, benzofuranic and indolic derivatives, their preparation process and pharmaceutical compositions containing them
04/05/2005CA2235138C Reverse-turn mimetics and methods relating thereto
04/05/2005CA2226671C 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors
04/05/2005CA2166975C Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists
04/05/2005CA2141209C Novel pyridyl- and pyrimidylpiperazine derivatives
04/05/2005CA2092694C Use of pyridylmethylsulphinyl-1h-benzimidazole derivates in the treatment of illnesses caused by helicobacter bacteria
04/05/2005CA1341478C Therapeutic methods using catalytic antibodies
04/01/2005CA2444161A1 A screening method of drug for treatment of neuropathic pain
03/2005
03/31/2005WO2005028667A1 Drug targeting g protein-coupled receptor expressed in human mast cells and method of screening the same
03/31/2005WO2005028631A2 A novel biodegradable elastomeric scaffold for tissue engineering and light scattering fingerprinting methods for testing the same
03/31/2005WO2005028617A2 Antisense inhibition of laminin-8 expression to inhibit human gliomas
03/31/2005WO2005028539A2 Multi-arm polymer prodrugs
03/31/2005WO2005028528A1 3,5-dimethyl-1-adamantyl-ammonium polymeric salts and the use thereof in the form of antiviral agents
03/31/2005WO2005028493A1 Antimicrobial derivatives
03/31/2005WO2005028491A1 Epimeredi glycoside a, the formulation containing thereof and their preparation method
03/31/2005WO2005028489A2 Novel adenosine a3 receptor agonists
03/31/2005WO2005028482A1 Polyether brevetoxin derivatives as a treatment for cystic fibrosis, mucociliary dysfunction, and pulmonary diseases
03/31/2005WO2005028481A2 Fused pentacyclic polyethers
03/31/2005WO2005028480A2 5-aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds
03/31/2005WO2005028479A2 Hiv replication inhibiting purine derivatives
03/31/2005WO2005028478A1 Aza-quinolinol phosphonate integrase inhibitor compounds
03/31/2005WO2005028477A1 Substituted diazabicycloalkane derivatives as ligands at alpha 7 nicotinic acety lcholine receptors
03/31/2005WO2005028475A2 Compositions useful as inhibitors of protein kinases
03/31/2005WO2005028474A2 Pyrazoloquinoline derivatives as chk-1 inhibitors
03/31/2005WO2005028473A1 Acyloxymethylcarbamate prodrugs of oxazolidinones
03/31/2005WO2005028471A1 Synthesis of quinoline 5-carboxamides useful for the preparation of pde iv inhibitors
03/31/2005WO2005028470A1 Quinazoline derivatives
03/31/2005WO2005028468A1 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridine-2-yl-amino]-propionic acid ethyl ester methane sulphonate and use thereof as a medicament
03/31/2005WO2005028467A1 Antibacterial 3,5-diaminopiperidine-substitute aromatic and heteroaromatic compounds
03/31/2005WO2005028464A1 Endurance improving agent
03/31/2005WO2005028462A1 Dimethoxy docetaxel acetone solvate et method for the preparation thereof
03/31/2005WO2005028456A1 Thiazole derivatives as cannabinoid receptor modulators
03/31/2005WO2005028455A1 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
03/31/2005WO2005028453A1 Phenylacetic acid derivative, process for producing the same, and use
03/31/2005WO2005028450A1 Polymorphic forms of a known antihyperlipemic agent
03/31/2005WO2005028448A1 Benzyl-benzimidazolyl derivatives
03/31/2005WO2005028444A1 1,4-disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases
03/31/2005WO2005028441A1 Cinnamoyl derivatives and use thereof
03/31/2005WO2005028440A1 Novel gamma secretase inhibitors
03/31/2005WO2005028438A1 Novel piperidine derivative
03/31/2005WO2005028434A2 Novel heterocyclic compounds as hsp90-inhibitors
03/31/2005WO2005028426A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor
03/31/2005WO2005028032A1 Injectable therapeutic formulations
03/31/2005WO2005028018A1 Fluid medication delivery device
03/31/2005WO2005027996A2 Application of a therapeutic substance to a tissue location using an expandable medical device
03/31/2005WO2005027988A2 Bone cement compositions having fiber-reinforcement and/or increased flowability
03/31/2005WO2005027981A1 Mechanism-based targeted pancreatic beta cell imaging and therapy
03/31/2005WO2005027977A2 Diclofenac compositions for the treatment of skin disorders
03/31/2005WO2005027975A1 Combinations of alpha-2-delta ligands and acetylcholinesterase inhibitors
03/31/2005WO2005027974A1 Anti cancer combinations comprising a cox-2 inhibitor
03/31/2005WO2005027972A2 Combination of a vegf receptor inhibitor with a chemotherapeutic agent
03/31/2005WO2005027971A1 Treatment of gastrointestinal stromal tumors with imatinib and midostaurin
03/31/2005WO2005027970A1 Drugs for treating cancer
03/31/2005WO2005027968A1 Remedy for down syndrome
03/31/2005WO2005027967A1 Medicinal composition
03/31/2005WO2005027962A1 4’-thionucleosides and oligomeric compounds
03/31/2005WO2005027957A1 Multiple-arm peptide compounds, methods of manufacture and use in therapy
03/31/2005WO2005027951A1 Method for controlling angiogenesis in animals
03/31/2005WO2005027950A1 Eye nutritional supplement
03/31/2005WO2005027949A1 Turmeric-containing composition
03/31/2005WO2005027948A1 Powdery composition for use as a laxative
03/31/2005WO2005027940A1 Cataplasm for repairing damaged skin
03/31/2005WO2005027939A1 Liquid formulations for the prevention and treatment of mucosal diseases and disorders
03/31/2005WO2005027938A1 Chemotherapeutic antineoplastic treatment
03/31/2005WO2005027937A1 Glycolipid-containing composition, use thereof and process for producing the same
03/31/2005WO2005027936A2 Pharmaceutical compositions and therapeutical treatment with oligo-beta-(1, 3)-glucans
03/31/2005WO2005027935A1 Carbohydrate composition and its use for the preparation of a medicament for treating or preventing pulmonary inflammation or acute respiration distress syndrome
03/31/2005WO2005027934A1 Prolyl oligopeptidase inhibitor
03/31/2005WO2005027933A1 Unsaturated phosphatidylcholines and uses thereof
03/31/2005WO2005027932A1 5-aminosalicylic acid solid preparation improved in discoloration and method of storing the same
03/31/2005WO2005027931A1 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an ep2 or ep4 selective agonist
03/31/2005WO2005027930A1 2-alkylene-19-nor-vitamin d derivatives for the treatment of osteosarcoma
1 ... 4733 4734 4735 4736 4737 4738 4739 4740 4741 4742 4743 4744 4745 4746 4747 4748 4749 4750 4751 4752 4753 ... 7860